Daniel A. Lawrence

About

Daniel A. Lawrence, PhD, is a University of Michigan cardiovascular-medicine researcher whose work focuses on vascular disease, stroke, atherosclerosis, thrombosis, fibrosis, and serpin biology. He is the scientific co-founder behind MDI Therapeutics, a biotech company built on technologies developed in his University of Michigan laboratory. Public sources present him as an academic and translational-science figure, not as an investor or fund manager.

Areas of interest